Maura Kadan

825 total citations
10 papers, 584 citations indexed

About

Maura Kadan is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Maura Kadan has authored 10 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Cancer Research. Recurrent topics in Maura Kadan's work include Cancer Genomics and Diagnostics (3 papers), Virus-based gene therapy research (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Maura Kadan is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Virus-based gene therapy research (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Maura Kadan collaborates with scholars based in United States. Maura Kadan's co-authors include Jung-Hwa Lim, M Gorziglia, S Yei, Bruce C. Trapnell, Rajyalakshmi Luthra, Luis A. Díaz, Martin A. Eglitis, W. French Anderson, Sabine Sturm and Theresa Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Virology.

In The Last Decade

Maura Kadan

10 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maura Kadan United States 6 273 268 174 157 83 10 584
Shalini Jindal Australia 9 267 1.0× 223 0.8× 236 1.4× 317 2.0× 71 0.9× 12 712
Lu Yao China 17 293 1.1× 404 1.5× 240 1.4× 417 2.7× 92 1.1× 51 1.1k
R Suzuki Japan 10 203 0.7× 377 1.4× 89 0.5× 113 0.7× 36 0.4× 16 799
Anna Karin Nilsson Sweden 15 131 0.5× 508 1.9× 91 0.5× 72 0.5× 44 0.5× 28 840
Meihua Song United States 14 228 0.8× 933 3.5× 335 1.9× 356 2.3× 53 0.6× 26 1.3k
Barbara Pietrucha Poland 12 114 0.4× 283 1.1× 84 0.5× 81 0.5× 36 0.4× 43 556
Sara Frı́as Mexico 18 317 1.2× 451 1.7× 136 0.8× 99 0.6× 50 0.6× 79 885
Carl Petersson Sweden 10 217 0.8× 174 0.6× 136 0.8× 109 0.7× 146 1.8× 12 493
Jennifer M. Spangle United States 13 82 0.3× 465 1.7× 169 1.0× 215 1.4× 43 0.5× 24 809
Marina Lanciotti Italy 17 215 0.8× 267 1.0× 60 0.3× 129 0.8× 23 0.3× 51 733

Countries citing papers authored by Maura Kadan

Since Specialization
Citations

This map shows the geographic impact of Maura Kadan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maura Kadan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maura Kadan more than expected).

Fields of papers citing papers by Maura Kadan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maura Kadan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maura Kadan. The network helps show where Maura Kadan may publish in the future.

Co-authorship network of co-authors of Maura Kadan

This figure shows the co-authorship network connecting the top 25 collaborators of Maura Kadan. A scholar is included among the top collaborators of Maura Kadan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maura Kadan. Maura Kadan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Anagnostou, Valsamo, Siân Jones, Karli Lytle, et al.. (2015). Personalized Genomic Analyses for Cancer Mutation Discovery and Interpretation.. Journal of Clinical Oncology. 33(15_suppl). 1529–1529. 3 indexed citations
2.
Murphy, Derek, Samuel V. Angiuoli, Bryan Chesnick, et al.. (2015). A comprehensive noninvasive approach for the stratification of lung cancer patients for targeted therapies.. Journal of Clinical Oncology. 33(15_suppl). e22086–e22086. 2 indexed citations
3.
Jones, Siân, Valsamo Anagnostou, Karli Lytle, et al.. (2015). Personalized genomic analyses for cancer mutation discovery and interpretation. Science Translational Medicine. 7(283). 283ra53–283ra53. 256 indexed citations
4.
Parpart-Li, Sonya, Samuel V. Angiuoli, Bryan Chesnick, et al.. (2015). Abstract 2405: A method for comprehensive genomic analysis of cell free DNA. Cancer Research. 75(15_Supplement). 2405–2405. 1 indexed citations
5.
Reese, Jennifer Barsky, Patrick H. Finan, Jennifer A. Haythornthwaite, et al.. (2013). Gastrointestinal ostomies and sexual outcomes: a comparison of colorectal cancer patients by ostomy status. Supportive Care in Cancer. 22(2). 461–468. 52 indexed citations
6.
Gorziglia, M, Maura Kadan, S Yei, et al.. (1996). Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy. Journal of Virology. 70(6). 4173–4178. 157 indexed citations
7.
Eglitis, Martin A., et al.. (1993). Introduction of human genomic sequences renders CHO-K1 cells susceptible to infection by amphotropic retroviruses. Journal of Virology. 67(2). 1100–1104. 5 indexed citations
8.
Kadan, Maura, Sabine Sturm, W. French Anderson, & Martin A. Eglitis. (1992). Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. Journal of Virology. 66(4). 2281–2287. 68 indexed citations
9.
Kadan, Maura & Paul Hartig. (1988). Autoradiographic localization and characterization of [125I]Lysergic acid diethylamide binding to serotonin receptors in Aplysia. Neuroscience. 24(3). 1089–1102. 17 indexed citations
10.
Hartig, Paul, et al.. (1983). 125I-LSD: A high sensitivity ligand for serotonin receptors. European Journal of Pharmacology. 89(3-4). 321–322. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026